Centre for Pharmaceutical Engineering Science wins ICURe Market Validation funding for its innovative 'SelfGel'� Technology
The team at CPES has recently developed "SelfGel" Technology which is a new bioadhesive gelling system.
The novel technology was designed to address the challenges faced by current gel based formulations when used in topical applications. Dr Sudhir Pagire, a Research and Knowledge Transfer Officer at the CPES was successful in securing £35,000 of funding from Innovate UK which will be used to accelerate the "Innovation to Commercialisation" journey of the "SelfGel" Technology. This initial funding will enable CPES to carry out market validation of the research-based business idea and Dr. Pagire will also receive intensive support in developing a structured business model.